Effects of chronic mental stress and atherogenic diet on the immune inflammatory environment in mouse aorta

Brain, Behavior, and Immunity

Volumn 25, Issue 8, 2011, Pages 1649-1657

  Marcondes, Maria Cecilia Garibaldi ^a   Zhukov, Viktor ^a   Bradlow, Henry ^a   Sanchez Alavez, Manuel ^a   Gonzalez, Alejandro Sanchez Alavez ^a   Curtiss, Linda K ^a   Conti, Bruno ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Adhesion molecules; Aorta; Atherogenesis; Atherosclerosis; Chronic stress; Diet; Inflammation; Neuropeptide Y

Indexed keywords

CHOLESTEROL; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; NEUROPEPTIDE Y; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTERY WALL; ARTICLE; ATHEROGENESIS; ATHEROGENIC DIET; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHOLESTEROL DIET; CHRONIC STRESS; CONTROLLED STUDY; DENDRITIC CELL; IMMOBILIZATION STRESS; INFLAMMATION; LEUKOCYTE ADHERENCE; MACROPHAGE; MENTAL STRESS; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ANIMALS; AORTA; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; CHRONIC DISEASE; DIET; DIET, ATHEROGENIC; E-SELECTIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNOENZYME TECHNIQUES; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; LEUKOCYTE COUNT; MALE; MICE; MICE, INBRED C57BL; NEUROPEPTIDE Y; PLAQUE, ATHEROSCLEROTIC; REAL-TIME POLYMERASE CHAIN REACTION; STRESS, PSYCHOLOGICAL; VASCULAR CELL ADHESION MOLECULE-1;

EID: 80053908762     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2011.06.007     Document Type: Article

References (59)

1. Barr A.M., Phillips A.G. Chronic mild stress has no effect on responding by rats for sucrose under a progressive ratio schedule. Physiol. Behav. 1998, 64:591-597.
2. Bedoui S., Kawamura N., Straub R.H., Pabst R., Yamamura T., von Horsten S. Relevance of neuropeptide Y for the neuroimmune crosstalk. J. Neuroimmunol. 2003, 134:1-11.
3. Black P.H. Stress and the inflammatory response: a review of neurogenic inflammation. Brain Behav. Immun. 2002, 16:622-653.
4. Bosma H., Marmot M.G., Hemingway H., Nicholson A.C., Brunner E., Stansfeld S.A. Low job control and risk of coronary heart disease in Whitehall II (prospective cohort) study. Bmj 1997, 314:558-565.
5. Bourdillon M.C., Poston R.N., Covacho C., Chignier E., Bricca G., McGregor J.L. ICAM-1 deficiency reduces atherosclerotic lesions in double-knockout mice (ApoE(-/-)/ICAM-1(-/-)) fed a fat or a chow diet. Arterioscler. Thromb. Vasc. Biol. 2000, 20:2630-2635.
6. Charbonneau H., Tonks N.K., Walsh K.A., Fischer E.H. The leukocyte common antigen (CD45): a putative receptor-linked protein tyrosine phosphatase. Proc. Natl. Acad. Sci. USA 1988, 85:7182-7186.
7. Cohen J.J. Thymus-derived lymphocytes sequestered in the bone marrow of hydrocortisone-treated mice. J. Immunol. 1972, 108:841-844.
8. Collins R.G., Velji R., Guevara N.V., Hicks M.J., Chan L., Beaudet A.L. P-selectin or intercellular adhesion molecule (ICAM)-1 deficiency substantially protects against atherosclerosis in apolipoprotein E-deficient mice. J. Exp. Med. 2000, 191:189-194.
9. Conti B., Jahng J.W., Tinti C., Son J.H., Joh T.H. Induction of interferon-gamma inducing factor in the adrenal cortex. J. Biol. Chem. 1997, 272:2035-2037.
10. Conti B., Sugama S., Kim Y., Tinti C., Kim H., Baker H., Volpe B., Attardi B., Joh T. Modulation of IL-18 production in the adrenal cortex following acute ACTH or chronic corticosterone treatment. NeuroImmunoModulation 2000, 8:1-7.
11. Curtiss L.K. ApoE in atherosclerosis: a protein with multiple hats. Arterioscler. Thromb. Vasc. Biol. 2000, 20:1852-1853.
12. Cybulsky M.I., Iiyama K., Li H., Zhu S., Chen M., Iiyama M., Davis V., Gutierrez-Ramos J.C., Connelly P.W., Milstone D.S. A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J. Clin. Invest. 2001, 107:1255-1262.
13. Dale D.C., Fauci A.S., Guerry D.I., Wolff S.M. Comparison of agents producing a neutrophilic leukocytosis in man. Hydrocortisone, prednisone, endotoxin, and etiocholanolone. J. Clin. Invest. 1975, 56:808-813.
14. Dansky H.M., Barlow C.B., Lominska C., Sikes J.L., Kao C., Weinsaft J., Cybulsky M.I., Smith J.D. Adhesion of monocytes to arterial endothelium and initiation of atherosclerosis are critically dependent on vascular cell adhesion molecule-1 gene dosage. Arterioscler. Thromb. Vasc. Biol. 2001, 21:1662-1667.
15. Dhabhar F.a.M. Bi-directional effects of stress on immune function: possible explanation for salubrious as well as harmful effects. Psychoneuroimmunology 2007, 2:7.
16. Dhabhar F.S., McEwen B.S. Stress-induced enhancement of antigen-specific cell-mediated immunity. J. Immunol. 1996, 156:2608-2615.
17. Dhabhar F.S., McEwen B.S. Acute stress enhances while chronic stress suppresses cell-mediated immunity in vivo: a potential role for leukocyte trafficking. Brain Behav. Immun. 1997, 11:286-306.
18. Dhabhar F.S., Viswanathan K. Short-term stress experienced at time of immunization induces a long-lasting increase in immunologic memory. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2005, 289:R738-R744.
19. Dhabhar F.S., Miller A.H., Stein M., McEwen B.S., Spencer R.L. Diurnal and acute stress-induced changes in distribution of peripheral blood leukocyte subpopulations. Brain Behav. Immun. 1994, 8:66-79.
20. Fantidis, P., 2010. The role of the stress-related anti-inflammatory hormones ACTH and cortisol in atherosclerosis. Curr. Vasc. Pharmacol. 8, 517-525.
21. Fauci A.S. Mechanisms of corticosteroid action on lymphocyte subpopulations. II. Differential effects of in vivo hydrocortisone, prednisone and dexamethasone on in vitro expression of lymphocyte function. Clin. Exp. Immunol. 1976, 24:54-62.
22. Fauci A.S., Dale D.C. The effect of in vivo hydrocortisone on subpopulations of human lymphocytes. J. Clin. Invest. 1974, 53:240-246.
23. Fauci A.S., Dale D.C. The effect of Hydrocortisone on the kinetics of normal human lymphocytes. Blood 1975, 46:235-243.
24. Furuhashi M., Hotamisligil G.S. Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets. Nat. Rev. Drug Discov. 2008, 7:489-503.
25. Furuhashi M., Fucho R., Gorgun C.Z., Tuncman G., Cao H., Hotamisligil G.S. Adipocyte/macrophage fatty acid-binding proteins contribute to metabolic deterioration through actions in both macrophages and adipocytes in mice. J. Clin. Invest. 2008, 118:2640-2650.
26. Galkina E., Ley K. Leukocyte influx in atherosclerosis. Curr. Drug Targets 2007, 8:1239-1248.
27. Galkina E., Ley K. Immune and inflammatory mechanisms of atherosclerosis (*). Annu. Rev. Immunol. 2009, 27:165-197.
28. Galkina E., Kadl A., Sanders J., Varughese D., Sarembock I.J., Ley K. Lymphocyte recruitment into the aortic wall before and during development of atherosclerosis is partially L-selectin dependent. J. Exp. Med. 2006, 203:1273-1282.
29. Ghiadoni L., Donald A.E., Cropley M., Mullen M.J., Oakley G., Taylor M., O'Connor G., Betteridge J., Klein N., Steptoe A., Deanfield J.E. Mental stress induces transient endothelial dysfunction in humans. Circulation 2000, 102:2473-2478.
30. Glass C.K., Witztum J.L. Atherosclerosis, the road ahead. Cell 2001, 104:503-516.
31. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 2005, 352:1685-1695.
32. Heid H.W., Moll R., Schwetlick I., Rackwitz H.R., Keenan T.W. Adipophilin is a specific marker of lipid accumulation in diverse cell types and diseases. Cell Tissue Res. 1998, 294:309-321.
33. Henry J.P., Ely D.L., Stephens P.M., Ratcliffe H.L., Santisteban G.A., Shapiro A.P. The role of psychosocial factors in the development of arteriosclerosis in CBA mice. Observations on the heart, kidney and aorta. Atherosclerosis 1971, 14:203-218.
34. Hulthe J., McPheat W., Samnegard A., Tornvall P., Hamsten A., Eriksson P. Plasma interleukin (IL)-18 concentrations is elevated in patients with previous myocardial infarction and related to severity of coronary atherosclerosis independently of C-reactive protein and IL-6. Atherosclerosis 2006, 188:450-454.
35. Kop W.J. Acute and chronic psychological risk factors for coronary syndromes: moderating effects of coronary artery disease severity. J. Psychosom. Res. 1997, 43:167-181.
36. Kop W.J. Chronic and acute psychological risk factors for clinical manifestations of coronary artery disease. Psychosom. Med. 1999, 61:476-487.
37. Krantz D.S., Kop W.J., Santiago H.T., Gottdiener J.S. Mental stress as a trigger of myocardial ischemia and infarction. Cardiol. Clin. 1996, 14:271-287.
38. Kumari M., Grahame-Clarke C., Shanks N., Marmot M., Lightman S., Vallance P. Chronic stress accelerates atherosclerosis in the apolipoprotein E deficient mouse. Stress 2003, 6:297-299.
39. Larigauderie G., Furman C., Jaye M., Lasselin C., Copin C., Fruchart J.C., Castro G., Rouis M. Adipophilin enhances lipid accumulation and prevents lipid efflux from THP-1 macrophages: potential role in atherogenesis. Arterioscler. Thromb. Vasc. Biol. 2004, 24:504-510.
40. Larigauderie G., Cuaz-Perolin C., Younes A.B., Furman C., Lasselin C., Copin C., Jaye M., Fruchart J.C., Rouis M. Adipophilin increases triglyceride storage in human macrophages by stimulation of biosynthesis and inhibition of beta-oxidation. FEBS J. 2006, 273:3498-3510.
41. Levine S. Influence of psychological variables on the activity of the hypothalamic-pituitary-adrenal axis. Eur. J. Pharmacol. 2000, 405:149-160.
42. Libby P. Atherosclerosis: the new view. Sci. Am. 2002, 286:46-55.
43. Luscher T.F., Yang Z., Tschudi M., von Segesser L., Stulz P., Boulanger C., Siebenmann R., Turina M., Buhler F.R. Interaction between endothelin-1 and endothelium-derived relaxing factor in human arteries and veins. Circ. Res. 1990, 66:1088-1094.
44. Lynch J.W., Everson S.A., Kaplan G.A., Salonen R., Salonen J.T. Does low socioeconomic status potentiate the effects of heightened cardiovascular responses to stress on the progression of carotid atherosclerosis?. Am. J. Public Health 1998, 88:389-394.
45. Makowski L., Hotamisligil G.S. Fatty acid binding proteins - the evolutionary crossroads of inflammatory and metabolic responses. J. Nutr. 2004, 134:2464S-2468S.
46. Makowski L., Boord J.B., Maeda K., Babaev V.R., Uysal K.T., Morgan M.A., Parker R.A., Suttles J., Fazio S., Hotamisligil G.S., Linton M.F. Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis. Nat. Med. 2001, 7:699-705.
47. McEwen B.S., Biron C.A., Brunson K.W., Bulloch K., Chambers W.H., Dhabhar F.S., Goldfarb R.H., Kitson R.P., Miller A.H., Spencer R.L., Weiss J.M. The role of adrenocorticoids as modulators of immune function in health and disease: neural, endocrine and immune interactions. Brain Res. Brain Res. Rev. 1997, 23:79-133.
48. Michel C., Duclos M., Cabanac M., Richard D. Chronic stress reduces body fat content in both obesity-prone and obesity-resistant strains of mice. Horm. Behav. 2005, 48:172-179.
49. Miller A.H., Spencer R.L., hassett J., Kim C., Rhee R., Ciurea D., Dhabhar F., McEwen B., Stein M. Effects of selective type I and II adrenal steroid agonists on immune cell distribution. Endocrinology 1994, 135:1934-1944.
50. Muller J.E., Abela G.S., Nesto R.W., Tofler G.H. Triggers, acute risk factors and vulnerable plaques: the lexicon of a new frontier. J. Am. Coll. Cardiol. 1994, 23:809-813.
51. Onsrud M., Thorsby E. Influence of in vivo hydrocortisone on some human blood lymphocyte subpopulations. I. Effect on natural killer cell activity. Scand. J. Immunol. 1981, 13:573-579.
52. Roberts E.S., Zandonatti M.A., Watry D.D., Madden L.J., Henriksen S.J., Taffe M.A., Fox H.S. Induction of pathogenic sets of genes in macrophages and neurons in NeuroAIDS. Am. J. Pathol. 2003, 162:2041-2057.
53. Roldan V., Marin F., Lip G.Y., Blann A.D. Soluble E-selectin in cardiovascular disease and its risk factors. A review of the literature. Thromb. Haemost. 2003, 90:1007-1020.
54. Sobey C.G. Neurogenic atherosclerosis mediated by neuropeptide y: hardening of the evidence. Arterioscler. Thromb. Vasc. Biol. 2003, 23:1137-1139.
55. Spain D.M., Thalhimer W. Temporary accumulation of eosinophilic leucocytes in spleen of mice following administration of cortisone. Proc. Soc. Exp. Biol. Med. 1951, 76:320-322.
56. Sung C.P., Arleth A.J., Feuerstein G.Z. Neuropeptide Y upregulates the adhesiveness of human endothelial cells for leukocytes. Circ. Res. 1991, 68:314-318.
57. Thom T., Haase N., Rosamond W., Howard V.J., Rumsfeld J., Manolio T., Zheng Z.J., Flegal K., O'Donnell C., Kittner S., Lloyd-Jones D., Goff D.C., Hong Y., Adams R., Friday G., Furie K., Gorelick P., Kissela B., Marler J., Meigs J., Roger V., Sidney S., Sorlie P., Steinberger J., Wasserthiel-Smoller S., Wilson M., Wolf P. Heart disease and stroke statistics-2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2006, 113:e85-e151.
58. Wang X., Reape T.J., Li X., Rayner K., Webb C.L., Burnand K.G., Lysko P.G. Induced expression of adipophilin mRNA in human macrophages stimulated with oxidized low-density lipoprotein and in atherosclerotic lesions. FEBS Lett. 1999, 462:145-150.
59. Williams R.B., Littman A.B. Psychosocial factors: role in cardiac risk and treatment strategies. Cardiol. Clin. 1996, 14:97-104.